Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Overview of venous thromboembolism.

Abad Rico JI, Llau Pitarch JV, Rocha E.

Drugs. 2010 Dec 14;70 Suppl 2:3-10. doi: 10.2165/1158583-S0-000000000-00000. Review.

PMID:
21162604
2.

Topical issues in venous thromboembolism.

Abad Rico JI, Llau Pitarch JV, Páramo Fernández JA.

Drugs. 2010 Dec 14;70 Suppl 2:11-8. doi: 10.2165/1158582-S0-000000000-00000. Review.

PMID:
21162605
3.

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR.

J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070. Review.

4.

Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.

Brown A.

Am J Health Syst Pharm. 2012 Mar 15;69(6):469-81. doi: 10.2146/ajhp110187. Review.

PMID:
22382477
5.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
6.

Venous thromboembolism in cancer patients.

Deng A, Galanis T, Graham MG.

Hosp Pract (1995). 2014 Dec;42(5):24-33. doi: 10.3810/hp.2014.12.1156. Review.

PMID:
25485915
7.

Anticoagulant use in real time.

Srinivasan D, Watzak B.

J Pharm Pract. 2013 Jun;26(3):270-9. doi: 10.1177/0897190012465950. Epub 2012 Nov 25. Review.

PMID:
23178414
8.

Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.

Al-Hameed F, Al-Dorzi HM, AlMomen A, Algahtani F, AlZahrani H, AlSaleh K, AlSheef M, Owaidah T, Alhazzani W, Neumann I, Wiercioch W, Brozek J, Schünemann H, Akl EA.

Ann Saudi Med. 2015 Mar-Apr;35(2):95-106. doi: 10.5144/0256-4947.2015.95.

9.

[Venous thromboembolism prophylaxis in internal medicine].

Malý J, Widimský J, Dulícek P.

Vnitr Lek. 2009 Mar;55(3):190-5. Review. Czech.

PMID:
19378845
10.

Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.

Al Sayegh F, Almahmeed W, Al Humood S, Marashi M, Bahr A, Al Mahdi H, Bakir S, Al Farhan M.

Clin Appl Thromb Hemost. 2009 May-Jun;15(3):289-96. doi: 10.1177/1076029608315168. Epub 2008 Apr 8.

PMID:
18400764
11.

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

12.

Thromboprophylaxis in non-surgical cancer patients.

Cohen AT, Gurwith MM, Dobromirski M.

Thromb Res. 2012 Apr;129 Suppl 1:S137-45. doi: 10.1016/S0049-3848(12)70034-8.

PMID:
22682125
13.

Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.

Hillis C, Crowther MA.

Thromb Haemost. 2015 Jun;113(6):1193-202. doi: 10.1160/TH14-12-1036. Epub 2015 May 7. Review. Erratum in: Thromb Haemost. 2015 Jul;114(1):210.

PMID:
25948149
14.

Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.

Kahn SR, Springmann V, Schulman S, Martineau J, Stewart JA, Komari N, McLeod A, Strulovitch C, Blostein M, Faucher JP, Gamble G, Gordon W, Kagoma PK, Miron MJ, Laverdière D, Game M, Mills A.

Thromb Haemost. 2012 Sep;108(3):493-8. doi: 10.1160/TH12-03-0169. Epub 2012 Jul 10.

PMID:
22782073
15.

Asian venous thromboembolism guidelines: prevention of venous thromboembolism.

Liew NC, Chang YH, Choi G, Chu PH, Gao X, Gibbs H, Ho CO, Ibrahim H, Kim TK, Kritpracha B, Lee LH, Lee L, Lee WY, Li YJ, Nicolaides AN, Oh D, Pratama D, Ramakrishnan N, Robless PA, Villarama-Alemany G, Wong R; Asian Venous Thrombosis Forum.

Int Angiol. 2012 Dec;31(6):501-16. Review.

PMID:
23222928
16.

Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.

Caprini JA, Tapson VF, Hyers TM, Waldo AL, Wittkowsky AK, Friedman R, Colgan KJ, Shillington AC; NABOR Steering Committee.

J Vasc Surg. 2005 Oct;42(4):726-33.

17.

Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.

Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P; Groupe Francophone Thrombose et Cancer (GFTC).

Thromb Res. 2010 Apr;125 Suppl 2:S108-16. doi: 10.1016/S0049-3848(10)70027-X. Review.

PMID:
20433988
18.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
19.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
20.

Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV).

Wang H, Sun Z, Jiang W, Zhang Y, Li X, Wu Y.

Vasc Med. 2015 Apr;20(2):117-21. doi: 10.1177/1358863X14564592. Epub 2015 Jan 19.

PMID:
25601917

Supplemental Content

Support Center